Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
151 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
152 Knowledge, perceptions and attitude of Egyptian physicians towards biobanking issues Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2021
153 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2021
154 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
 		Department of Biostatistics and Cancer Epidemiology Basma Rezk Farouk Saleh 2021
155 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
 		Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
156 Laparoscopic versus Open Complete Mesocolic Excision for Right Colon Cancer Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2021
157 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute Department of Radiotherapy and Nuclear medicine Dr. Dalia Osama Mohamed Ahmed 2021
158 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
159 Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
160 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021